BioBusiness Seminar Central Nervous System
After the great success of the first edition of BioBusiness Seminar we will follow up on March 30th 2010 with the second edition. The BioBusiness Seminars are an initiative of Van Leeuwenhoeck Research and Hyphen Projects. The Seminars will provide an excellent platform for young and promising European life sciences companies to present themselves to potential investors and big pharmaceutical companies. The format of the Seminars will accommodate personal meetings between investors and the presenting companies.
The theme of the second edition is Central Nervous System. Several of the most promising European biotech companies that are active in the field of CNS will present themselves on this day:
· Galapagos - Andre Hoekema, Senior VP Corp Dev
· PAION – Wolfgang Soehngen, Chief Executive Officer
· Evotec – John Kemp, Chief Research and Development Officer
· To-BBB – Pieter Gaillard, Chief Scientific Officer
· BioTie Therapies - Thomas Kronbach, Chief Scientific Officer
· NovotiQ – Rene van der Linden, Chief Executive Officer
· University of Leiden, LACDR - Dr. Roel de Rijk
Click here to see the full program
Among the already registered delegates are key people from organizations like Merck Serono Ventures, Life Sciences Partners, Johnson & Johnson, UCB Pharma and Sanofi-aventis.
Click here to register online for the BioBusiness Seminar Central Nervous System.
Or click here to download the participant guide and registration form.
 |
 |
|
Partners: |
Silver Sponsor:
| |
 |
 |
|
